183 related articles for article (PubMed ID: 35497797)
1. Genetic Variants of
Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA;
Kidney Int Rep; 2022 Apr; 7(4):786-796. PubMed ID: 35497797
[TBL] [Abstract][Full Text] [Related]
2. Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV.
Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Fox J; Burns F; Harber M; Ustianowski A; Hamzah L; Burns JE; Clarke A; Price DA; Kegg S; Onyango D; Santana-Suarez B; Campbell L; Bramham K; Sharpe CC; Sabin CA; Winkler CA; Post FA;
Kidney Int Rep; 2022 Mar; 7(3):465-473. PubMed ID: 35257059
[TBL] [Abstract][Full Text] [Related]
3. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
[TBL] [Abstract][Full Text] [Related]
4.
Young BA; Wilson JG; Reiner A; Kestenbaum B; Franceschini N; Bansal N; Correa A; Himmelfarb J; Katz R
Kidney Med; 2021; 3(6):962-973.e1. PubMed ID: 34939005
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations.
Brandenburg JT; Govender MA; Winkler CA; Boua PR; Agongo G; Fabian J; Ramsay M
Clin J Am Soc Nephrol; 2022 Jun; 17(6):798-808. PubMed ID: 35577564
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of kidney disease in people of African ancestry with HIV in the UK.
Hung RKY; Santana-Suarez B; Binns-Roemer E; Campbell L; Bramham K; Hamzah L; Fox J; Burns JE; Clarke A; Vincent R; Jones R; Price DA; Onyango D; Harber M; Hilton R; Booth JW; Sabin CA; Winkler CA; Post FA;
EClinicalMedicine; 2021 Aug; 38():101006. PubMed ID: 34286237
[TBL] [Abstract][Full Text] [Related]
7. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
[TBL] [Abstract][Full Text] [Related]
8. APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study.
Chaudhary NS; Tiwari HK; Hidalgo BA; Limdi NA; Reynolds RJ; Cushman M; Zakai NA; Lange L; Judd SE; Winkler CA; Kopp JB; Gutiérrez OM; Irvin MR
Am J Nephrol; 2022; 53(2-3):182-190. PubMed ID: 35100591
[TBL] [Abstract][Full Text] [Related]
9. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
[TBL] [Abstract][Full Text] [Related]
10. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
11. Host factors predisposing to kidney disease in people with HIV.
Hung RKY; Winkler CA; Post FA
Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
[TBL] [Abstract][Full Text] [Related]
12. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.
Waziri B; Raji YE; Ekrikpo UE; Naicker S
J Nephrol; 2023 May; 36(4):1119-1134. PubMed ID: 36510118
[TBL] [Abstract][Full Text] [Related]
15. APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program.
Hung AM; Shah SC; Bick AG; Yu Z; Chen HC; Hunt CM; Wendt F; Wilson O; Greevy RA; Chung CP; Suzuki A; Ho YL; Akwo E; Polimanti R; Zhou J; Reaven P; Tsao PS; Gaziano JM; Huffman JE; Joseph J; Luoh SW; Iyengar S; Chang KM; Casas JP; Matheny ME; O'Donnell CJ; Cho K; Tao R; Susztak K; Robinson-Cohen C; Tuteja S; Siew ED;
JAMA Intern Med; 2022 Apr; 182(4):386-395. PubMed ID: 35089317
[TBL] [Abstract][Full Text] [Related]
16. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
Kormann R; Jannot AS; Narjoz C; Ribeil JA; Manceau S; Delville M; Joste V; Prié D; Pouchot J; Thervet E; Courbebaisse M; Arlet JB
Br J Haematol; 2017 Oct; 179(2):323-335. PubMed ID: 28699644
[TBL] [Abstract][Full Text] [Related]
17. Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways.
Bajaj A; Ihegword A; Qiu C; Small AM; Wei WQ; Bastarache L; Feng Q; Kember RL; Risman M; Bloom RD; Birtwell DL; Williams H; Shaffer CM; Chen J; Center RG; Denny JC; Rader DJ; Stein CM; Damrauer SM; Susztak K
Kidney Int; 2020 May; 97(5):1032-1041. PubMed ID: 32247630
[TBL] [Abstract][Full Text] [Related]
18. HIV Viremia Is Associated With
Kruzel-Davila E; Sankofi BM; Kubi Amos-Abanyie E; Ghansah A; Nyarko A; Agyemang S; Awandare GA; Szwarcwort-Cohen M; Reiner-Benaim A; Hijazi B; Ulasi I; Raji YR; Boima V; Osafo C; May Adabayeri V; Matekole M; Olanrewaju TO; Ajayi S; Mamven M; Antwi S; Ademola AD; Plange-Rhule J; Arogundade F; Akyaw PA; Winkler CA; Salako BL; Ojo A; Skorecki K; Adu D
Front Med (Lausanne); 2021; 8():718300. PubMed ID: 34513880
[TBL] [Abstract][Full Text] [Related]
19.
Ekulu PM; Nkoy AB; Betukumesu DK; Aloni MN; Makulo JRR; Sumaili EK; Mafuta EM; Elmonem MA; Arcolino FO; Kitetele FN; Lepira FB; van den Heuvel LP; Levtchenko EN
Kidney Int Rep; 2019 Jul; 4(7):930-938. PubMed ID: 31317115
[TBL] [Abstract][Full Text] [Related]
20. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
